{"database": "lobbying", "table": "lobbying_activities", "rows": [[2461072, "243a51c0-4899-4cdd-a929-ff67b6b11f6f", "Q2", "EAST END GROUP, LLC", 400646949, "BAYER CORPORATION", 2020, "second_quarter", "HCR", "General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislative and regulatory issues related to COVID-19 response.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 45000, null, 0, 0, "2020-07-03T12:01:33.143000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2461072"], "units": {}, "query_ms": 89.66239308938384, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}